Equities

Delko SA

DEL:WSE

Delko SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (PLN)9.28
  • Today's Change0.00 / 0.00%
  • Shares traded3.14k
  • 1 Year change-14.47%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Delko SA is a Poland-based company involved in household products distribution. The Company is principally engaged in the wholesale of fast-moving consumer goods (FMCG), primarily cosmetics, personal hygiene and household cleaning products, as well as groceries and tobacco, across Poland. The Company’s partners include Unilever, Gillette, Bella, Lambi and Dove, among others. Moreover, the Company offers products under its own brands, such as Filip, Filip Fresh, Blue, Teak, Delikato, Oskar, Tanius, Granit, Domowy, Delko Professional and others. The Company operates through three segments: Wholesale, Retail through own grocery and chemist stores, and Retail through a franchising network. The distribution is conducted through regional sales representatives, the Company's own network of warehouses, as well as direct service for main retail clients.

  • Revenue in PLN (TTM)882.32m
  • Net income in PLN15.21m
  • Incorporated2001
  • Employees1.15k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Harper Hygienics SA-100.00bn-100.00bn32.15m584.00--0.5080----------9.94-----------0.7789---1.45--22.20---0.82150.8666--0.609--5.54--104.34------
4Mass SA103.73m17.45m34.19m103.008.902.411.690.32960.72680.72684.322.681.371.3011.931,007,106.0023.0017.2626.3020.6161.2654.3216.8212.201.4931.850.0479--51.7957.43113.18101.58----
Miraculum SA47.80m-3.47m38.00m54.00--1.25--0.795-0.077-0.0771.090.63810.80972.227.71885,167.30-5.88-5.49-7.97-7.5034.1632.61-7.26-8.880.3884-0.59480.3014--8.6616.1833.44---11.53--
Pharmena SA291.00k28.98m55.35m15.001.914.481.90190.222.602.600.02611.110.00890.58320.129519,400.0088.311.111,064.195.1127.1555.399,958.081.8711.31--0.0125--0.00-53.00628.36---6.78--
Delko SA882.32m15.21m110.99m1.15k7.300.69433.450.12581.271.2773.7713.372.520.163810.53769,916.304.34--7.48--98.30--1.72--0.7472556.190.3919--------------
PCC Exol SA915.71m27.63m428.38m332.0015.510.93239.530.46780.15860.15865.262.641.058.686.632,852,667.003.178.444.0911.4416.9819.533.026.830.93492.420.37627.66-19.708.31-64.7316.7130.68-4.90
Dr Miele Cosmed Group SA483.07m35.95m443.68m536.0012.341.749.230.91850.41160.41165.532.921.214.959.05901,251.909.013.6013.295.2843.0238.287.443.400.63477.840.2096--12.088.121,080.63--3.79--
Data as of Nov 21 2024. Currency figures normalised to Delko SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

1.48%Per cent of shares held by top holders
HolderShares% Held
Attitude Gesti�n SGIIC SAas of 30 Jun 2024176.58k1.48%
Millennium TFI SAas of 31 Dec 20230.000.00%
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.